Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1958 3
1959 1
1961 1
1964 1
1965 2
1966 2
1967 1
1968 3
1970 2
1971 1
1972 4
1973 3
1974 2
1975 3
1976 2
1977 4
1978 2
1979 4
1980 4
1981 6
1982 6
1983 7
1984 11
1985 7
1986 11
1987 8
1988 8
1989 19
1990 12
1991 15
1992 14
1993 25
1994 24
1995 28
1996 40
1997 36
1998 44
1999 45
2000 43
2001 43
2002 72
2003 93
2004 121
2005 148
2006 153
2007 192
2008 224
2009 270
2010 321
2011 347
2012 431
2013 492
2014 634
2015 658
2016 670
2017 756
2018 798
2019 935
2020 1088
2021 1263
2022 157
Text availability
Article attribute
Article type
Publication date

Search Results

9,281 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Sun JM, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Mansoor W, Li SH, Sunpaweravong P, Maqueda MA, Goekkurt E, Hara H, Antunes L, Fountzilas C, Tsuji A, Oliden VC, Liu Q, Shah S, Bhagia P, Kato K; KEYNOTE-590 Investigators. Sun JM, et al. Among authors: shen l. Lancet. 2021 Aug 28;398(10302):759-771. doi: 10.1016/S0140-6736(21)01234-4. Lancet. 2021. PMID: 34454674 Clinical Trial.
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Janjigian YY, Kawazoe A, Yañez P, Li N, Lonardi S, Kolesnik O, Barajas O, Bai Y, Shen L, Tang Y, Wyrwicz LS, Xu J, Shitara K, Qin S, Van Cutsem E, Tabernero J, Li L, Shah S, Bhagia P, Chung HC. Janjigian YY, et al. Among authors: shen l. Nature. 2021 Dec;600(7890):727-730. doi: 10.1038/s41586-021-04161-3. Epub 2021 Dec 15. Nature. 2021. PMID: 34912120
Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species.
Zhang XJ, Liu X, Hu M, Zhao GJ, Sun D, Cheng X, Xiang H, Huang YP, Tian RF, Shen LJ, Ma JP, Wang HP, Tian S, Gan S, Xu H, Liao R, Zou T, Ji YX, Zhang P, Cai J, Wang ZV, Meng G, Xu Q, Wang Y, Ma XL, Liu PP, Huang Z, Zhu L, She ZG, Zhang X, Bai L, Yang H, Lu Z, Li H. Zhang XJ, et al. Among authors: shen lj. Cell Metab. 2021 Oct 5;33(10):2059-2075.e10. doi: 10.1016/j.cmet.2021.08.014. Epub 2021 Sep 17. Cell Metab. 2021. PMID: 34536344
Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
Wang Y, Yang L, Bao H, Fan X, Xia F, Wan J, Shen L, Guan Y, Bao H, Wu X, Xu Y, Shao Y, Sun Y, Tong T, Li X, Xu Y, Cai S, Zhu J, Zhang Z. Wang Y, et al. Among authors: shen l. PLoS Med. 2021 Aug 31;18(8):e1003741. doi: 10.1371/journal.pmed.1003741. eCollection 2021 Aug. PLoS Med. 2021. PMID: 34464382 Free PMC article.
Circulating tumor cells: biology and clinical significance.
Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, Zhu F, Zhou D, Zheng S, Chen Y, Zhou J. Lin D, et al. Among authors: shen l. Signal Transduct Target Ther. 2021 Nov 22;6(1):404. doi: 10.1038/s41392-021-00817-8. Signal Transduct Target Ther. 2021. PMID: 34803167 Free PMC article. Review.
ZAP70, too little, too much can lead to autoimmunity.
Ashouri JF, Lo WL, Nguyen TTT, Shen L, Weiss A. Ashouri JF, et al. Among authors: shen l. Immunol Rev. 2021 Dec 18. doi: 10.1111/imr.13058. Online ahead of print. Immunol Rev. 2021. PMID: 34923645 Review.
9,281 results